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SUMMARY: Rabbit nasal olfactory agd respiratory microsomes 
demonstrate high activity toward [ HI-(S)-nicotine, with specific 
activities of 22.2 and 6.5 nmol/min/mg protefQ:5qespectively. The 
major metabolite produced is (S)-nicotine A -iminium ion, with 
lesser amounts of nornicotine and the N'-oxide. Reconstitution of 
the rabbit nasal microsomal system with cytochromes P-450 NMa and NMb 
indicated that only P-450 NMa has significant activity toward 
nicotine, and the metabolite profile and turnover are similar to that 
obse ved with nasal microsomes. 
min -If 
The low K (35 e(M) and high V 
suggest that a significant portion 8f inhaled nicotine feX 
(28 
) 
metabolized by nasal tissues in the rabbit. o 1990 Academic Press, Inc. 
(S)-Nicotine is the major pharmacologically active component of 
inhaled tobacco and is primarily responsible for tobacco addiction. 
The metabolism of nicotine (reviewed in ref. 1) in mammals is 
catalyzed predominantly by two microsomal monooxygenase systems, the 
cytochrome P-450-dependent mixed-function oxidase system and the 
flavin-containing monooxygenase. Two major metabolites of nicotine 
are derived from oxidation at either the 5' -carbon to yield initially 
the Al"5' -iminium ion, which is further metabolized by cytosolic 
aldehyde oxidase to cotinine, or at the pyrrolidine nitrogen to give 
the N' -oxide. The formation of the Al"5' -iminium ion is catalyzed 
by cytochromes P-450, and numerous studies have indicated that the P- 
450s belonging to the IIB sub-family have high activity in this 
reaction (2-5). N'-oxidation of (S)- and (R)-nicotine is catalyzed 
efficiently by liver flavin-containing monooxygenase (6). In a 
general sense, P-450-dependent C5 '-oxidation can be regarded as 
bioactivation, as most covalent binding observed following exposure 
to nicotine occurs through the iminium ion (7). Tertiary amine N- 
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oxides, however, such as nicotine N'-oxide, are highly hydrophilic, 
easily excreted metabolites generally thought to represent 
detoxication (8). 
Most studies performed on nicotine metabolism have focused on 
liver. However, as nasal and other respiratory tissues are the 
initial tissues exposed, it is of importance to determine the 
capacity of these tissues for metabolism of this alkaloid. A number 
of studies have recently demonstrated that the levels and activity of 
cytochromes P-450 are relatively high in nasal tissues of a number of 
mammals (9,lO) with specific contents ranging from 8-41% of that 
found in liver (10). The activity of nasal microsomes toward a 
number of xenobiotics, when expressed on a per nmol P-450 basis are 
actually significantly higher than activities seen in liver 
microsomes. These examples include known or suspected nasal 
carcinogens such as hexamethylphosphoramide and N-nitrosodiethylamine 
(11). 
The relative roles of cytochromes P-450 and flavin-containing 
monooxygenase in the metabolism of (S)-nicotine in rabbit lung has 
recently been examined (12). The major metabolite produced by rabbit 
lung microsomes is the iminium ion, and P-450 form 2 (IIBI) accounts 
for essentially all of the P-450-dependent formation of this 
metabolite. Rabbit lung flavin-containing monooxygenase, which has 
previously been demonstrated to exhibit substrate specificities which 
distinguish it from the liver enzyme (13-15), has very low activity 
toward N'-oxidation of (S)-nicotine. The high C5 '-oxidation by P-450 
2, the low N '-oxidation by flavin-containing monooxygenase, and the 
relatively low levels of aldehyde oxidase in lung may all be 
contributing factors to the relatively high levels of covalent 
binding to macromolecules observed upon incubation of [3H]-(S)- 
nicotine with rabbit lung microsomes (7). 
Recently, two novel forms of P-450 (P-450s NMa and NMb) have 
been purified from rabbit nasal microsomes (11). Rabbit P-450 NMa 
exhibits high activity toward a number of xenobiotics, including 
hexamethylphosphoramide, phenacetin, N-nitrosodiethylamine and 
ethanol, whereas P-450 NMb displays high activity toward an 
endogenous substrate, testosterone. In this study, we have found 
that rabbit P-450 NMa very efficiently catalyzes the oxidation of (S)- 
nicotine, producing predominantly the A1"5'-iminium ion. The 
metabolic profile of P-450 NMa in the reconstituted system and the 
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high turnover number (28 min 
-1 ) are consistent with the postulate 
that the high nicotine oxidase activity observed with rabbit nasal 
microsomes is due to P-450 NMa. 
EXPERIMENTAL PROCEDURES 
Materials: (S)-Nicotine, (S)-[5'-3H]-nicotine, (S)-nicotine A1’j5’- 
iminium ion aperchlorate, nicotine N'-oxide and nornicotine were 
generously provided by Dr. Neal Castagnoli, Jr., (Virginia 
Polytechnic Inst. and State University, Blacksburg, VA). NADPH, 
dilauroylphosphatidylcholine (DLPC), DL-isocitrate and isocitrate 
dehydrogenase (EC 1.1.1.42, Type IV from porcine heart) were 
purchased from Sigma Chem. Co., (St. Louis, MO). Triethylamine (gold 
label) was obtained from Aldrich Chem. Co., (Milwaukee, WI). 
Tissues and enzvmes: Frozen nasal tissue from male adult New Zealand 
White (NZW) rabbits was obtained from Pel-Free2 Biol., (Rogers, AR) 
and microsomes were prepared as described previously (16). The nasal 
maxillary turbinals were used for the preparation of respiratory 
microsomes, while the ethmoturbinals and the septa were combined for 
the preparation of olfactory microsomes. The purification and 
partial characterization of rabbit nasal cytochromes P-450 NMa and 
NMb have been published (11). Rabbit lung P-450 2 was purified from 
lung microsomes of pregnant NZW rabbits (Pel-Freez) using the 
procedure of Guengerich (17). NADPH-cytochrome P-450 reductase was 
purified from rabbit liver microsomes using the procedure of 
Yasukochi and Masters (18). 
Nicotine oxidation: The microsomal incubations were performed in 
microcentrifuge tubes in a total volume of 0.1 ml. The assay system 
was composed of 0.05 mg of microsomal protein in 0.05 M Tris-HCl 
buffer, pH 7.5, 5 mM MgC12, 1 mM EDTA with an NADPH-regenerating 
system (0.02 M i3ocitrate, 0.025 U isocitrate dehydrogenase and 1 mM 
NADPH). (S)-[5- HI-Nicotine was present at a concentration of 0.5 mM 
(64 @/pmol, added from a 10 mM stock in 20% ethanol, 0.1 N HCl). 
All of the reactiog components, excluding the microsomes, were 
preincubated at 37 C for 2 min prior to initiation of the reaction by 
the addition of the microsomes. The reaction was carried out at 37 C 
with shaking for O-40 min and terminated by the addition of 0.1 ml of 
methanol. The tubes were incubated on ice for 30 min and then the 
precipitated proteins were pelleted by centrifugation at 16,000 rpm 
in a microcentrifuge (Beckman Microfuge E) at 4 C for 10 min. An 
aliquot of the supernatant layer was injected directly onto3the HPLC 
column (Beckman Ultrasphere ODS, 5 m, 4.6 x 250 mm) and [ H]- 
nicotine and metabolites were resolved by an isocratic system of 20% 
acetonitrile:methanol (7:3) and 80% 0.03 M sodium phosphate, pH 7.0, 
containing 0.1% triethylamine, at a flow rate of 1 ml/min (Shimadzu 
Model LC-6A pumps and SCL-GA system controller). Quantitation was 
performed with an on-line radioisotope detector (Beckman Model 171) 
equipped with a liquid flow cell; the scintillation fluid (RPI 
3a70B) flow rate was 2 ml/min. Peak identification was by co-elution 
(uv detection at 260 nm with a Shimadzu Model SPD-6AV) with the 
following standards: 
(3.7 min), 
(S)-nicotine N/-oxide (3.$,m$p), nornicotine 
cotinine (5.7 min)! (S)-nicotine A ’ 
min)3and (S)-nicotine (10.5 min). 
iminium ion (7.2 
and H on two separate channels 
The results were plotted as A260 
and the radioactivity peaks 
integrated utilizing a ChromatoGraphics software program from 
Beckman. 
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Rabbit lung cytochrome P-450 nicotine oxidase was assayed by 
reconstituting 0.01-0.05 nmol of P-450 with a 2.5-fold molar excess 
of NADPH-cytochrome P-450 reductase and 2 pg of DLPC (added from a 
0.1% stock in water sonicated just prior to use) at room temperature 
for 10 min. Following the preincubation, the remaining assay 
components were added, excluging NADPH, and the system was 
preincubated for 2 mjn at 37 C prior to initiation of the reaction 
with NADPH. (S)-[5- HI-Nicotine was added at levels of 0.01-O-5 mM. 
The reaction time was varied (lo-40 min) in the kinetic studies, with 
the (S)-nicotine concentration adjusted to maintain initial velocity 
rates as much as possible. The subsequent termination of the 
reaction and metabolite analysis was as described above. 
RESULTS AND DISCUSSION 
Incubation of rabbit olfactory and respiratory nasal microsomes, 
at a concentration of 0.5 mg of microsomal protein per ml, with 0.5 
mM (S)-[3H]-nicotine resulted in a roughly linear rate of nicotine 
oxidase activity between 2-40 min (Fig. 1). Essentially all of the 
3H incorporated into metabolites could be accounted for as (S)- 
nicotine-N'oxide, nornicotine and the iminium ion. Rabbit nasal 
microsomes resemble rabbit lung microsomes in producing primarily the 
iminium ion, with lesser amounts of nornicotine and the N'-oxide 
(Table I). The sum of total metabolites derived from (S)-nicotine 
was 22.2 and 6.46 nmol/min/mg protein for rabbit nasal olfactory and 
respiratory microsomes, respectively. Although, on a per mg protein 
basis, the olfactory microsomes display almost 4-fold higher 
NICOTINE OXIDATION BY NASAL MICROSOMES 
7nn 
Time (min) 
Figure 1. The metabolism of (S)-[5-3 HI-nicotine by rabbit nasal 
microsomes as a function of time. The total nicotine 
oxidase (N*-oxide, nornicotine and iminium ion) activity 
of rabbit nasal olfactory (open circles) and respiratory 
(closed circles) microsomes was determined by incubating 
0.05 mg of micg&omal protein with 0.5 mM (ST-[5-=H]- 
nicotine at 37 C with shakinq for 2, 5, 10, 20 or 40 
min. The remaining assay coiponents were & described in 
Materials and Methods. Data points represent the mean of 
duplicates. 
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Table I 
Metabolism of (S)-Nicotine by Microsomes From 
Rabbit Nasal and Lung Tissue 
Microsomes Nicotine Oxidase Activity 
(nmol products/min/mq protein) 
a 
N'-oxide Nornicotine Iminium Ion Total 
Nasal Olfactory 6.67 5.17 10.4 22.2 
(35.8)b 
Nasal Respiratory 0.84 1.57 4.05 6.46 
(28.1) 
Lung 3.01 0.95 4.67 8.63 
(18.81 
EThe values given represent the average of duplicate determinations. 
Values in parentheses are calculated as nmol/min/nmol total P-450. 
activity, if the results are expressed as turnover numbers (nmol of 
nicotine oxidized/min/nmol total microsomal P-450), the activities 
are roughly equal (35.8 and 28.1 min -1 for olfactory and respiratory, 
respectively). The microsomes from both regions of the nasal tissue 
displayed activities (on a per nmol P-450 basis) about 2-fold higher 
than rabbit lung microsomes (Table I). The lung microsomes were 
obtained from pregnant NZW rabbits and the nasal microsomes were from 
adult male NZW rabbits (both from Pel-Freez Biol.), and, therefore, a 
direct comparison of activities between tissues may not be 
appropriate. 
Previous studies, using immunoblotting techniques to determine 
the isozyme composition of rabbit tissues had documented that nasal 
microsomes contain P-450s 2, 3a, 4 and 5 (19,20). Williams et al -A
(12) and McCoy et al. (21) have shown that, of these four isozymes, 
P-450 2 displays the highest activity toward nicotine. The 
activities of reconstituted rabbit nasal P45Os NMa and NMb toward (S)- 
nicotine were compared to rabbit lung P-450 2 (Table II). (S)- 
Nicotine oxidation was catalyzed most efficiently by P-450 NMa, which 
displayed lo-fold higher activity than P-450 NMb. These results 
would be consistent with the finding of Ding and Coon (11) that P-450 
NMa displays higher activity than P-450 NMb toward xenobiotics such 
as hexamethylphosphoramide, phenacetin, N-nitrosodiethylamine and 
ethanol, whereas NMb has a higher turnover with the endogenous 
substrate testosterone. The metabolite profile of purified P-450 NMa 
in the reconstituted system resembles that of the nasal microsomes in 
that the iminium ion is the major product, but there are also 
significant amounts of nornicotine and N'-oxide produced. Rabbit 
nasal P-450 NMa oxidized (S)-nicotine at least 4 times as rapidly as 
P-450 2 (Table II). The turnover number given for P-450 NMa (9.01 
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Table II 
Nicotine metabolism by rabbit P-450s in the reconstituted system 
Rabbit P-450 Nicotine Oxidase Activity 
(nmol/min/nmol P-450) 
N'-oxide Nor-tine Total Imj.nj&m Ion 
Nasal P-450 NMa 1.11 2.15 5.75 9.01 
Nasal P-450 NMb 0.62 NDb 0.31 0.93 
buna p-450 2 . 0.74 0.91 2.07 
aRabbit P-450s (0.05 nmol) were reconstituted with a 2.5 molar excess 
of NADPH-cytochrome P-450 reductase and 
Materials and Methods. 
2 pg of DLPC as describes in 
The reaction was allowed to proceed at 37 C 
6 or 40 min. Not detectable. 
min -1 ) was not a true Vmax, as under the conditions used in Table I 
(0.05 nmol, 40 min incubation with 0.5 mM (S)-nicotine), 70-80% of 
the parent compound had been metabolized. (See Fig. 2.) 
In order to get a more accurate estimate of the Vmax and Km of P- 
450 NMa-dependent oxidation of (S)-nicotine, the activity of the 
reconstituted enzyme system with concentrations of (S)-nicotine from 
0.01-0.5 mM was determined under conditions which ensured initial 
‘; 
5. 













\ 0.00 0.02 0.04 0.06 0.08 0.10 0.12 
Vmor = 28 min-’ 
Km = 35pM 
Figure 2. Kinetics of (S)-[5-'II]-nicotine oxidation by nasal P-450 
NMa in the reconstituted system. P-450 NMa (0.01 nmol) 
was reconstituted with rabbit liver NADPH-cytochrome P-450 
reductase (0.025 nmol) and 2 vg DLPC as described3in 
Materials and Methods. The metabolism of (S)-[5- HI- 
nicotine was determined at substrate concentrations of 
0.01, 0.02, 0.05, 0.1, 0.25 and 0.5 mM. The incubation 
times were 10, 20 and 40 min for the lowest, middle and 
highest substrate concentrations, respectively (in order 
to ensure initital velocities). The values shown are the 
mean (t S.E.) of triplicates or the mean of duplicates. 
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rates (see Materials and Methods). Linear regression analysis of the 
double-reciprocal plot obtained yielded a Vmax of 28 mine1 (total 
metabolites) and a Km of 35 PM. This turnover number with 
reconstituted P-450 NMa compares well with the turnover exhibited by 
nasal microsomes (Table I), suggesting that P-450 NMa catalyzes most 
of the nicotine oxidation in these microsomes. For comparison, 
previous work (12) had determined that rabbit P-450 2 had a Vmax of 
1.5 min -1 (iminium ion only) and a Km of 70 HM. Therefore, the 
rabbit P-450 which had previously been demonstrated to have the 
highest activity toward nicotine had a maximum velocity about lo-fold 
less than rabbit nasal P-450 NMa and a Km about 2-fold higher. In a 
study by McCoy et al. (21), rabbit P-450 2 exhibited a turnover of 35 
min -' (C- plus N-oxidation) and the turnover with other rabbit P-450s 
(3a, 3b, 3c, 4 and 6) ranged from 2.4-38.0 min 
-1 . These incubations 
were performed with 30 mM nicotine, and the differences between our 
results and those of McCoy et al. are similar to those observed in 
previously published turnover numbers of various rabbit P-450 
isozymes with N-nitrosodimethylamine (22). At a concentration of 0.1 
mM N-nitrosodimethylamine, only rabbit P-450 form 3a displayed 
significant N-demethylation activity, whereas all the P-450s 
displayed significant activities at a substrate concentration of 100 
mM. 
In summary, we have demonstrated that rabbit nasal microsomes 
1’,5’ readily metabolize (S)-nicotine to (S)-nicotine A -iminium ion, 
nornicotine and (S)-nicotine N'-oxide. Most of the nicotine 
oxidation in rabbit nasal microsomes appears to be due to the 
activity of a novel form of P-450 recently purified by Ding and Coon 
(11) and termed P-450 NMa. P-450 NMa also exhibits relatively high 
activity toward hexamethylphosphoramide, phenacetin, N- 
nitrosodiethylamine and ethanol. The formation of relatively large 
amounts of nicotine A 11,5' -iminium ion, an electrophilic metabolite 
responsible for much of the nicotine-derived covalent binding to 
macromolecules in nasal tissue, is consistent with previous studies 
documenting covalent adducts in nasal tissue from tobacco smoke (23) 
and a possible epidemiological correlation between smoking and 
cancers of the nasal cavity (24). 
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